{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:22:21Z","timestamp":1787563341704,"version":"build-2736575974"},"reference-count":18,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,15]]},"abstract":"<jats:p>Trypanosomes are a group of protozoan parasites that inflict huge health and economic burdens across the globe. The African trypanosome, Trypanosoma brucei, the causative agent of sleeping sickness, has a highly sophisticated mechanism of antigenic variation that facilitates chronic survival in the mammalian host, and also all but eliminates any realistic hope for vaccination-based control. However, trypanosomes are also highly divergent organisms, with many biochemical processes setting them apart from their hosts, and there remains great optimism that these features may be exploited for development of new drugs. Unfortunately, the compounds that are in use at present are decades old and resistance has emerged. The article in this issue of the Biochemical Journal by Patham et al., a joint team from the universities of Pittsburgh and Georgia, represents one approach to exploiting this divergence. The authors of the study have exploited novel aspects of the biochemistry within the system for translocation of nascent polypeptides across the endoplasmic reticulum membrane to identify three compounds that are able to inhibit the process. They then demonstrate that these same compounds are both trypanocidal, but well tolerated by human tissue culture cells. These observations may present interesting new leads in the fight against trypanosomiasis, and potentially identify a new target that can be explored for therapeutic potential.<\/jats:p>","DOI":"10.1042\/bj20090283","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T07:12:14Z","timestamp":1238137934000},"page":"e1-e3","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug screening by crossing membranes: a novel approach to identification of trypanocides"],"prefix":"10.1042","volume":"419","author":[{"given":"Mark\u00a0C.","family":"Field","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2009,3,27]]},"reference":[{"key":"2021112214395599700_B1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"2021112214395599700_B2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1073\/pnas.0711799105","article-title":"Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: Trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei","volume":"105","author":"Lai","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214395599700_B3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(95)90673-8","article-title":"Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness","volume":"89","author":"P\u00e9pin","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"(8)","key":"2021112214395599700_B4","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda","volume":"1","author":"Priotto","year":"2006","journal-title":"PLoS Clin. Trials."},{"key":"2021112214395599700_B5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.331.7527.1238","article-title":"Sleeping sickness in Uganda: a thin line between two fatal diseases","volume":"331","author":"Picozzi","year":"2005","journal-title":"BMJ"},{"key":"2021112214395599700_B6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2008.07.006","article-title":"Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis","volume":"108","author":"Thuita","year":"2008","journal-title":"Acta Trop."},{"issue":"(7)","key":"2021112214395599700_B7","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1371\/journal.pbio.0060185","article-title":"Antigenic variation in Trypanosoma brucei: joining the DOTs","volume":"6","author":"Stockdale","year":"2008","journal-title":"PLoS Biol."},{"key":"2021112214395599700_B8","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1073\/pnas.0501886102","article-title":"Variant surface glycoprotein RNA interference triggers a pre-cytokinesis cell cycle arrest in African trypanosomes","volume":"102","author":"Sheader","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214395599700_B9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/QCO.0b013e3282ef6172","article-title":"Pre-erythrocytic malaria vaccine development","volume":"20","author":"Mikolajczak","year":"2007","journal-title":"Curr. Opin. Infect. Dis."},{"key":"2021112214395599700_B10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/311167a0","article-title":"6A-resolution X-ray structure of a variable surface glycoprotein from Trypanosoma brucei","volume":"311","author":"Freymann","year":"1984","journal-title":"Nature"},{"key":"2021112214395599700_B11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.3340856","article-title":"Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane","volume":"239","author":"Ferguson","year":"1988","journal-title":"Science"},{"key":"2021112214395599700_B12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1083\/jcb.103.1.255","article-title":"Post-translational modification and intracellular transport of a trypanosome variant surface glycoprotein","volume":"103","author":"Bangs","year":"1986","journal-title":"J. Cell Biol."},{"key":"2021112214395599700_B13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/BJ20081787","article-title":"Post-translational import of protein into the endoplasmic reticulum of a trypanosome: an in vitro system for discovery of anti-trypanosomal chemical entities","volume":"419","author":"Patham","year":"2009","journal-title":"Biochem. J."},{"key":"2021112214395599700_B14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.114.1.61","article-title":"Transfer of glycosyl-phosphatidylinositol membrane anchors to polypeptide acceptors in a cell-free system","volume":"114","author":"Mayor","year":"1991","journal-title":"J. Cell Biol."},{"key":"2021112214395599700_B15","doi-asserted-by":"crossref","first-page":"47348","DOI":"10.1074\/jbc.M207736200","article-title":"RNA interference of signal peptide-binding protein SRP54 elicits deleterious effects and protein sorting defects in trypanosomes","volume":"277","author":"Liu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112214395599700_B16","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1242\/jcs.02578","article-title":"The Trypanosoma brucei signal recognition particle lacks the Alu-domain-binding proteins: purification and functional analysis of its binding proteins by RNAi","volume":"118","author":"Lustig","year":"2005","journal-title":"J. Cell Sci."},{"key":"2021112214395599700_B17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jmb.2008.05.049","article-title":"Demonstration of a multistep mechanism for assembly of the SRP x SRP receptor complex: implications for the catalytic role of SRP RNA","volume":"381","author":"Zhang","year":"2008","journal-title":"J. Mol. Biol."},{"key":"2021112214395599700_B18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/EC.00141-06","article-title":"Chromosome-wide analysis of gene function by RNA interference in the African trypanosome","volume":"5","author":"Subramaniam","year":"2006","journal-title":"Eukaryot. Cell."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/419\/2\/e1\/659630\/bj419e001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/419\/2\/e1\/659630\/bj419e001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T13:47:27Z","timestamp":1637588847000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/419\/2\/e1\/45355\/Drug-screening-by-crossing-membranes-a-novel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,27]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20090283","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,27]]}}}